• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对 IFN-γ 的致病性自身抗体通过阻碍受体组装和 Fc 介导的反应发挥作用。

Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response.

机构信息

Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.

Division of Biophysics, Department of Biology, University of Osnabruck, Osnabruck, Germany.

出版信息

J Exp Med. 2022 Sep 5;219(9). doi: 10.1084/jem.20212126. Epub 2022 Jul 14.

DOI:10.1084/jem.20212126
PMID:35833912
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9287643/
Abstract

Anti-interferon (IFN)-γ autoantibodies (AIGAs) are a pathogenic factor in late-onset immunodeficiency with disseminated mycobacterial and other opportunistic infections. AIGAs block IFN-γ function, but their effects on IFN-γ signaling are unknown. Using a single-cell capture method, we isolated 19 IFN-γ-reactive monoclonal antibodies (mAbs) from patients with AIGAs. All displayed high-affinity (KD < 10-9 M) binding to IFN-γ, but only eight neutralized IFN-γ-STAT1 signaling and HLA-DR expression. Signal blockade and binding affinity were correlated and attributed to somatic hypermutations. Cross-competition assays identified three nonoverlapping binding sites (I-III) for AIGAs on IFN-γ. We found that site I mAb neutralized IFN-γ by blocking its binding to IFN-γR1. Site II and III mAbs bound the receptor-bound IFN-γ on the cell surface, abolishing IFN-γR1-IFN-γR2 heterodimerization and preventing downstream signaling. Site III mAbs mediated antibody-dependent cellular cytotoxicity, probably through antibody-IFN-γ complexes on cells. Pathogenic AIGAs underlie mycobacterial infections by the dual blockade of IFN-γ signaling and by eliminating IFN-γ-responsive cells.

摘要

抗干扰素 (IFN)-γ 自身抗体 (AIGAs) 是导致迟发性免疫缺陷伴播散性分枝杆菌和其他机会性感染的致病因素。AIGAs 阻断 IFN-γ 功能,但它们对 IFN-γ 信号的影响尚不清楚。我们使用单细胞捕获方法从 AIGAs 患者中分离出 19 种 IFN-γ 反应性单克隆抗体 (mAb)。所有 mAb 均显示出对 IFN-γ 的高亲和力(KD < 10-9 M)结合,但只有 8 种 mAb 能中和 IFN-γ-STAT1 信号和 HLA-DR 表达。信号阻断和结合亲和力相关,并归因于体细胞超突变。交叉竞争测定确定了 AIGAs 在 IFN-γ 上的三个非重叠结合位点 (I-III)。我们发现,位点 I mAb 通过阻断其与 IFN-γR1 的结合来中和 IFN-γ。位点 II 和 III mAb 结合细胞表面结合受体的 IFN-γ,从而阻止 IFN-γR1-IFN-γR2 异二聚体形成并阻止下游信号。位点 III mAb 介导抗体依赖性细胞毒性,可能是通过细胞上的抗体-IFN-γ 复合物。致病性 AIGAs 通过双重阻断 IFN-γ 信号和消除 IFN-γ 反应性细胞,导致分枝杆菌感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/ff5a4effa6d9/JEM_20212126_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/5048d7305229/JEM_20212126_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/90f984d75133/JEM_20212126_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/1d8e92790c46/JEM_20212126_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/2f1e2fc33c4c/JEM_20212126_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/0122afad1053/JEM_20212126_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/4aeb0c5cc01b/JEM_20212126_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/b1e705dc001e/JEM_20212126_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/0848b91fe49b/JEM_20212126_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/94774d6b32e4/JEM_20212126_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/d4c922552551/JEM_20212126_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/12710241059d/JEM_20212126_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/ff5a4effa6d9/JEM_20212126_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/5048d7305229/JEM_20212126_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/90f984d75133/JEM_20212126_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/1d8e92790c46/JEM_20212126_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/2f1e2fc33c4c/JEM_20212126_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/0122afad1053/JEM_20212126_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/4aeb0c5cc01b/JEM_20212126_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/b1e705dc001e/JEM_20212126_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/0848b91fe49b/JEM_20212126_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/94774d6b32e4/JEM_20212126_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/d4c922552551/JEM_20212126_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/12710241059d/JEM_20212126_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aff/9287643/ff5a4effa6d9/JEM_20212126_FigS5.jpg

相似文献

1
Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response.针对 IFN-γ 的致病性自身抗体通过阻碍受体组装和 Fc 介导的反应发挥作用。
J Exp Med. 2022 Sep 5;219(9). doi: 10.1084/jem.20212126. Epub 2022 Jul 14.
2
Patient iPSC-Derived Macrophages to Study Inborn Errors of the IFN-γ Responsive Pathway.患者诱导多能干细胞衍生巨噬细胞用于研究 IFN-γ 反应途径的先天性错误。
Cells. 2020 Feb 19;9(2):483. doi: 10.3390/cells9020483.
3
Partial interferon-gamma receptor deficiency and non-tuberculous mycobacterial lung disease.部分γ-干扰素受体缺陷与非结核分枝杆菌肺病
Tuberculosis (Edinb). 2006 Sep;86(5):382-5. doi: 10.1016/j.tube.2005.11.002. Epub 2006 May 8.
4
IFN-γR1 defects: Mutation update and description of the IFNGR1 variation database.IFN-γR1 缺陷:突变更新和 IFNGR1 变异数据库描述。
Hum Mutat. 2017 Oct;38(10):1286-1296. doi: 10.1002/humu.23302. Epub 2017 Aug 3.
5
Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-γ.由于对 IFN-γ 的反应受损,MSMD 患者的破骨细胞生成增强。
J Allergy Clin Immunol. 2022 Jan;149(1):252-261.e6. doi: 10.1016/j.jaci.2021.05.018. Epub 2021 Jun 24.
6
Intact IFN-γR1 expression and function distinguishes Langerhans cell histiocytosis from mendelian susceptibility to mycobacterial disease.IFN-γR1 表达和功能完整可将朗格汉斯细胞组织细胞增生症与先天性分枝杆菌病相区别。
J Clin Immunol. 2014 Jan;34(1):84-93. doi: 10.1007/s10875-013-9959-1. Epub 2013 Nov 20.
7
Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.抗干扰素-γ自身抗体在成人免疫缺陷中的中和活性与其结合结构域相关。
Front Immunol. 2019 Aug 14;10:1905. doi: 10.3389/fimmu.2019.01905. eCollection 2019.
8
Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease.鉴定分枝杆菌病患者中抗干扰素-γ自身抗体的主要表位。
Nat Med. 2016 Sep;22(9):994-1001. doi: 10.1038/nm.4158. Epub 2016 Aug 15.
9
Anti-interferon-γ autoantibody-associated immunodeficiency.抗干扰素-γ自身抗体相关性免疫缺陷。
Curr Opin Immunol. 2021 Oct;72:206-214. doi: 10.1016/j.coi.2021.05.007. Epub 2021 Jun 25.
10
A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.一种新型的细胞类型特异性部分 IFN-γR1 缺乏症,由 IFNGR1 起始密码子的种系突变引起。
Hum Mol Genet. 2010 Feb 1;19(3):434-44. doi: 10.1093/hmg/ddp507. Epub 2009 Oct 31.

引用本文的文献

1
Anti-interferon-γ autoantibodies syndrome and opportunistic infections: systematic literature review.抗干扰素-γ自身抗体综合征与机会性感染:系统文献综述
Front Immunol. 2025 Aug 29;16:1615091. doi: 10.3389/fimmu.2025.1615091. eCollection 2025.
2
Characteristics of polyclonal anti-interferon-gamma autoantibodies and novel diagnostic strategies: A prospective cohort study of new biomarkers.多克隆抗干扰素-γ自身抗体的特征及新型诊断策略:新生物标志物的前瞻性队列研究
J Transl Autoimmun. 2025 May 15;10:100292. doi: 10.1016/j.jtauto.2025.100292. eCollection 2025 Jun.
3
Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response.

本文引用的文献

1
Mendelian susceptibility to mycobacterial diseases: state of the art.孟德尔易感性对分枝杆菌病:最新进展。
Clin Microbiol Infect. 2022 Nov;28(11):1429-1434. doi: 10.1016/j.cmi.2022.03.004. Epub 2022 Mar 11.
2
Fc-engineered antibodies with immune effector functions completely abolished.具有免疫效应功能的 Fc 工程化抗体完全被消除。
PLoS One. 2021 Dec 21;16(12):e0260954. doi: 10.1371/journal.pone.0260954. eCollection 2021.
3
Mycobacterial diseases in patients with inborn errors of immunity.免疫缺陷患者的分枝杆菌病。
慢性乙型肝炎病毒感染者体内常存在抗干扰素自身抗体,且与聚乙二醇干扰素α治疗无应答相关。
JHEP Rep. 2025 Feb 28;7(5):101382. doi: 10.1016/j.jhepr.2025.101382. eCollection 2025 May.
4
Human immunity to fungal infections.人类对真菌感染的免疫力。
J Exp Med. 2025 Jun 2;222(6). doi: 10.1084/jem.20241215. Epub 2025 Apr 15.
5
A Proteomics Outlook on the Molecular Effectors of CAR-T Cell Therapy in Cancer Management.嵌合抗原受体T细胞(CAR-T)疗法在癌症治疗中分子效应器的蛋白质组学展望
J Proteome Res. 2025 Jun 6;24(6):2571-2583. doi: 10.1021/acs.jproteome.4c00930. Epub 2025 Mar 6.
6
Clinical characteristics of acquired anti-IFN-γ autoantibodies in patients infected with non-tuberculous mycobacteria: a prospective cohort study.非结核分枝杆菌感染患者获得性抗干扰素-γ自身抗体的临床特征:一项前瞻性队列研究。
BMC Pulm Med. 2025 Feb 27;25(1):95. doi: 10.1186/s12890-025-03566-4.
7
Exploring the Contrasts and Similarities of Dengue and SARS-CoV-2 Infections During the COVID-19 Era.探讨 COVID-19 时代登革热和 SARS-CoV-2 感染的差异与相似之处。
Int J Mol Sci. 2024 Oct 29;25(21):11624. doi: 10.3390/ijms252111624.
8
A sensitive assay for measuring whole-blood responses to type I IFNs.一种用于测量 I 型干扰素对全血反应的敏感测定法。
Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2402983121. doi: 10.1073/pnas.2402983121. Epub 2024 Sep 23.
9
Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations.不同序贯 COVID-19 疫苗接种诱导的不同 BCR 利用和 T 细胞激活。
mBio. 2024 Oct 16;15(10):e0142924. doi: 10.1128/mbio.01429-24. Epub 2024 Sep 9.
10
The Pathogenic Role of Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Nocardiosis with the Central Nervous System Involvement.抗粒细胞-巨噬细胞集落刺激因子自身抗体在伴有中枢神经系统受累的诺卡氏菌病中的致病作用。
J Clin Immunol. 2024 Aug 12;44(8):176. doi: 10.1007/s10875-024-01775-w.
Curr Opin Immunol. 2021 Oct;72:262-271. doi: 10.1016/j.coi.2021.07.001. Epub 2021 Jul 24.
4
Anti-interferon-γ autoantibody-associated immunodeficiency.抗干扰素-γ自身抗体相关性免疫缺陷。
Curr Opin Immunol. 2021 Oct;72:206-214. doi: 10.1016/j.coi.2021.05.007. Epub 2021 Jun 25.
5
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.APS-1 患者中预先存在的 I 型干扰素自身抗体是导致严重 COVID-19 肺炎的基础。
J Exp Med. 2021 Jul 5;218(7). doi: 10.1084/jem.20210554.
6
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
7
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.从新冠肺炎患者中纵向分离出强效的近胚系严重急性呼吸综合征冠状病毒2中和抗体
Cell. 2020 Sep 17;182(6):1663-1673. doi: 10.1016/j.cell.2020.08.046.
8
Anti-IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections.抗 IFN-γ 自身抗体是播散性马尔尼菲青霉感染的基础。
J Exp Med. 2020 Dec 7;217(12). doi: 10.1084/jem.20190502.
9
Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?自身抗体对抗细胞因子:原发性免疫缺陷的表型模拟?
Hum Genet. 2020 Jun;139(6-7):783-794. doi: 10.1007/s00439-020-02180-0. Epub 2020 May 17.
10
Mendelian susceptibility to mycobacterial disease: recent discoveries.孟德尔易感性对分枝杆菌病的影响:最新发现。
Hum Genet. 2020 Jun;139(6-7):993-1000. doi: 10.1007/s00439-020-02120-y. Epub 2020 Feb 5.